Jackson Square Partners, LLC Charles River Laboratories International, Inc. Transaction History
Jackson Square Partners, LLC
- $1.15 Billion
- Q3 2024
A detailed history of Jackson Square Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Jackson Square Partners, LLC holds 161,925 shares of CRL stock, worth $25.1 Million. This represents 2.78% of its overall portfolio holdings.
Number of Shares
161,925
Previous 178,226
9.15%
Holding current value
$25.1 Million
Previous $36.8 Million
13.36%
% of portfolio
2.78%
Previous 2.27%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
51.4MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$954 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$788 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$579 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$330 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$300 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.88B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...